These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39303384)

  • 1. Engineering of exosome-liposome hybrid-based theranostic nanomedicines for NIR-II fluorescence imaging-guided and targeted NIR-II photothermal therapy of subcutaneous glioblastoma.
    Liu Y; Li M; Gu J; Huang H; Xie H; Yu C; Roy S; Chen X; Kuang T; Zhang Y; Jiang S; Guo B
    Colloids Surf B Biointerfaces; 2025 Jan; 245():114258. PubMed ID: 39303384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-activity nanozyme as an oxygen pump to alleviate tumor hypoxia and enhance photodynamic/ NIR-II photothermal therapy for sniping oral squamous cell carcinoma.
    Li X; Hao M; Liu A; Li L; Nešić MD; Yang B; Liu W; Lin Q
    Acta Biomater; 2024 Dec; 190():476-487. PubMed ID: 39401597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor Microenvironment-triggered protein-binding Near-infrared-II Theranostic nanoplatform for Mild-Temperature photothermal therapy.
    Huang W; Jin B; Gong H; Ali N; Jiang D; Shan T; Zhang L; Tian J; Zhang W
    J Colloid Interface Sci; 2025 Feb; 680(Pt B):375-388. PubMed ID: 39577235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of nanotheranostics in the second near-infrared window in bioimaging and cancer treatment.
    Li H; Li P; Zhang J; Lin Z; Bai L; Shen H
    Nanoscale; 2024 Dec; 16(47):21697-21730. PubMed ID: 39508492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIR-activated Janus nanomotors with promoted tumor permeability for synergistic photo-immunotherapy.
    Zhang Y; Xing Y; Zhou H; Ma E; Xu W; Zhang X; Jiang C; Ye S; Deng Y; Wang H; Li J; Zheng S
    Acta Biomater; 2024 Dec; 190():463-475. PubMed ID: 39490462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4T1 Cell Membrane-Coated Pdots with NIR-II Absorption and Fluorescence Properties for Targeted Phototheranostics of Breast Tumors.
    Guo J; Liu Y; Liang X; Chen Z; Liu B; Yuan Z
    ACS Appl Mater Interfaces; 2024 Dec; 16(48):66425-66435. PubMed ID: 39569810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with NIR-II probes: review on state-of-the-art tools and strategies.
    Yang Y; Jiang S; Stanciu SG; Peng H; Wu A; Yang F
    Mater Horiz; 2024 Nov; 11(23):5815-5842. PubMed ID: 39207201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIR-activated multifunctional agents for the combined application in cancer imaging and therapy.
    Repetowski P; Warszyńska M; Dąbrowski JM
    Adv Colloid Interface Sci; 2024 Nov; 336():103356. PubMed ID: 39612723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermo-responsive gold nanorod vesicles for combined NIR-II photothermal therapy and chemotherapy of solid tumors.
    Xing W; Li T; Yang G; Wu S; Pang B; Xu Y; Qian X; Zhu W
    Acta Biomater; 2024 Nov; ():. PubMed ID: 39603577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFP Farnesylation as a Suitable Strategy for Selectively Tagging Exosomes.
    Piccarducci R; Germelli L; Falleni A; Luisotti L; Masciulli B; Signore G; Migone C; Fabiano A; Bizzarri R; Piras AM; Giacomelli C; Marchetti L; Martini C
    ACS Appl Bio Mater; 2024 Dec; 7(12):8305-8318. PubMed ID: 39632747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice.
    Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N
    Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking Drugs and Lipids: Quantitative Mass Spectrometry Imaging of Liposomal Doxorubicin Delivery and Bilayer Fate in Three-Dimensional Tumor Models.
    Lopez A; Holbrook JH; Kemper GE; Lukowski JK; Andrews WT; Hummon AB
    Anal Chem; 2024 Jun; 96(22):9254-9261. PubMed ID: 38778440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical and functional design considerations for a real-world interpretable AI solution for NIR perfusion analysis (including cancer).
    Moynihan A; Boland P; Cucek J; Erzen S; Hardy N; McEntee P; Rojc J; Cahill R
    Eur J Surg Oncol; 2024 Dec; 50(12):108273. PubMed ID: 38538505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual pH-responsive polypeptide nanoprobes for lysosomes enhanced bioimaging and tumor photothermal therapy under 1064 nm irradiation.
    Wang Y; Xu Y; Chen D; Li X; Yin D; Yan L
    Int J Biol Macromol; 2024 Dec; 282(Pt 5):137177. PubMed ID: 39488318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects of nano-theranostic approaches against breast and cervical cancer.
    Ria T; Roy R; Mandal US; Sk UH
    Biochim Biophys Acta Rev Cancer; 2024 Nov; 1879(6):189227. PubMed ID: 39612962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occlusal interventions for managing temporomandibular disorders.
    Singh BP; Singh N; Jayaraman S; Kirubakaran R; Joseph S; Muthu MS; Jivnani H; Hua F
    Cochrane Database Syst Rev; 2024 Sep; 9(9):CD012850. PubMed ID: 39282765
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.